- Home
- ATAI
as 12-20-2024 3:31pm EST
ATAI Life Sciences NV is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. Its product candidates include COMP360/Psilocybin therapy, PCN-101/R-ketamine, RL-007/Compound, DMX-1002/Ibogaine, GRX-917/Deuterated etifoxine, VLS-01/DMT, EMP-01/MDMA derivative, RLS-01/Salvinorin A, KUR-101/Deuterated Mitragynine, and DMX-1001/Noribogaine. The business operates geographically in two regions being the United States and Germany.
| Founded: | 2018 | Country: | Germany |
| Employees: | N/A | City: | BERLIN |
| Market Cap: | 214.8M | IPO Year: | 2021 |
| Target Price: | $9.00 | AVG Volume (30 days): | 1.2M |
| Analyst Decision: | Strong Buy | Number of Analysts: | 4 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.80 | EPS Growth: | N/A |
| 52 Week Low/High: | $1.03 - $2.85 | Next Earning Date: | 11-13-2024 |
| Revenue: | $331,000 | Revenue Growth: | -0.90% |
| Revenue Growth (this year): | 93.15% | Revenue Growth (next year): | -36.93% |
Latest ATAI Life Sciences N.V. News
ATAI Breaking Stock News: Dive into ATAI Ticker-Specific Updates for Smart Investing
Simply Wall St.
a month ago
Oxbridge Re Holdings Among 3 US Penny Stocks To Watch
GlobeNewswire
a month ago
atai Life Sciences Reports Third Quarter 2024 Financial Results and Provides Corporate Updates
GlobeNewswire
a month ago
Altimmune Appoints Life Sciences Industry Veteran Greg Weaver as Chief Financial Officer
Simply Wall St.
2 months ago
374Water And 2 Other Promising US Penny Stocks To Watch
GlobeNewswire
2 months ago
atai Life Sciences to Participate in the 2024 Maxim Healthcare Virtual Summit
GlobeNewswire
4 months ago
atai Life Sciences to Participate in the H.C. Wainwright 26th Annual Global Investment Conference
GlobeNewswire
4 months ago
atai Life Sciences Reports Second Quarter 2024 Financial Results and Provides Corporate Updates
GlobeNewswire
4 months ago
atai Life Sciences Announces Positive Preliminary Results from Phase 1b Trial of VLS-01 (Buccal Film DMT)
Compare ATAI vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "ATAI ATAI Life Sciences N.V. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.